Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
470.52
+4.91 (1.05%)
Feb 4, 2026, 4:00 PM EST - Market closed
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Buy
Price Target
$512.63
Upside
+8.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Buy Upgrades $414 → $606 | Hold → Buy | Upgrades | $414 → $606 | +28.79% | Jan 28, 2026 |
| UBS | UBS | Strong Buy Maintains $535 → $545 | Strong Buy | Maintains | $535 → $545 | +15.83% | Jan 26, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $475 → $530 | Buy | Maintains | $475 → $530 | +12.64% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $455 → $546 | Hold → Buy | Upgrades | $455 → $546 | +16.04% | Jan 22, 2026 |
| Bernstein | Bernstein | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jan 12, 2026 |
| UBS | UBS | Strong Buy Initiates $546 → $535 | Strong Buy | Initiates | $546 → $535 | +13.70% | Jan 7, 2026 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $548 | Hold → Buy | Upgrades | $548 | +16.47% | Jan 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $456 → $525 | Buy | Maintains | $456 → $525 | +11.58% | Dec 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $460 → $515 | Buy | Maintains | $460 → $515 | +9.45% | Dec 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $516 → $564 | Buy | Maintains | $516 → $564 | +19.87% | Dec 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $438 → $516 | Hold → Buy | Upgrades | $438 → $516 | +9.67% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $553 → $546 | Strong Buy | Maintains | $553 → $546 | +16.04% | Nov 7, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $423 → $415 | Hold | Maintains | $423 → $415 | -11.80% | Nov 4, 2025 |
| Barclays | Barclays | Hold Maintains $408 → $414 | Hold | Maintains | $408 → $414 | -12.01% | Nov 4, 2025 |
| Stifel | Stifel | Hold Maintains $455 → $445 | Hold | Maintains | $455 → $445 | -5.42% | Nov 4, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $439 → $438 | Hold | Maintains | $439 → $438 | -6.91% | Oct 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.